Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127974161 | 12797416 | 1 | I | 20160924 | 0 | 20160929 | 20160929 | DIR | US-FDA-351778 | FDA-CTU | 75.00 | YR | M | N | 71.55000 | KG | 20160929 | N | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127974161 | 12797416 | 1 | PS | ZETIA | EZETIMIBE | 1 | Oral | ? QUANTITY:9 TABLET(S);? | Y | D | M015515 | 20190228 | 0 | 9 | DF | COATED TABLET | HS | ||
| 127974161 | 12797416 | 2 | C | CARVEDILOL. | CARVEDILOL | 1 | 0 | ||||||||||||
| 127974161 | 12797416 | 3 | C | LISINOPRIL. | LISINOPRIL | 1 | 0 | ||||||||||||
| 127974161 | 12797416 | 4 | C | POTASSIUM CHLORIDE. | POTASSIUM CHLORIDE | 1 | 0 | ||||||||||||
| 127974161 | 12797416 | 5 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 0 | ||||||||||||
| 127974161 | 12797416 | 6 | C | GABAPENTIN. | GABAPENTIN | 1 | 0 | ||||||||||||
| 127974161 | 12797416 | 7 | C | CHOLESTYRAMININE LIGHT | 2 | 0 | |||||||||||||
| 127974161 | 12797416 | 8 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 0 | ||||||||||||
| 127974161 | 12797416 | 9 | C | MORPHINE SULFATE ER | MORPHINE SULFATE | 1 | 0 | ||||||||||||
| 127974161 | 12797416 | 10 | C | TESTOSTERONE. | TESTOSTERONE | 1 | 0 | ||||||||||||
| 127974161 | 12797416 | 11 | C | OXYBUTYNIN | OXYBUTYNIN | 1 | 0 | ||||||||||||
| 127974161 | 12797416 | 12 | C | CIALIS | TADALAFIL | 1 | 0 | ||||||||||||
| 127974161 | 12797416 | 13 | C | ALPRAZOLAM. | ALPRAZOLAM | 1 | 0 | ||||||||||||
| 127974161 | 12797416 | 14 | C | ASPIRIN. | ASPIRIN | 1 | 0 | ||||||||||||
| 127974161 | 12797416 | 15 | C | NASACORT | TRIAMCINOLONE ACETONIDE | 1 | 0 | ||||||||||||
| 127974161 | 12797416 | 16 | C | OMEGA 3 FISH OIL | FISH OILOMEGA-3 FATTY ACIDS | 1 | 0 | ||||||||||||
| 127974161 | 12797416 | 17 | C | VITAMIN D | CHOLECALCIFEROL | 1 | 0 | ||||||||||||
| 127974161 | 12797416 | 18 | C | GRAPE SEED EXTRACT | GRAPE SEED EXTRACT | 1 | 0 | ||||||||||||
| 127974161 | 12797416 | 19 | C | ANTACID-CA RICH | 2 | 0 | |||||||||||||
| 127974161 | 12797416 | 20 | C | MILK OF MAGNESIA | MAGNESIUM HYDROXIDE | 1 | 0 | ||||||||||||
| 127974161 | 12797416 | 21 | C | MULTI VITAMIN | VITAMINS | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127974161 | 12797416 | 1 | Blood cholesterol increased |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127974161 | 12797416 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127974161 | 12797416 | Arthralgia | |
| 127974161 | 12797416 | Asthenia | |
| 127974161 | 12797416 | Fatigue | |
| 127974161 | 12797416 | Head discomfort | |
| 127974161 | 12797416 | Myalgia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127974161 | 12797416 | 1 | 20160914 | 20160923 | 0 |